Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Other Non Operating Income came in at -$10.0 million in Q4 2025, up 15.27% year-on-year from -$8.7 million in Q4 2024, and down 1897.01% quarter-over-quarter from -$501000.0 in Q3 2025.

Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Other Non Operating Income history runs 16 years deep, the most recent figure standing at -$10.0 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 15.27% year-over-year to -$10.0 million in Q4 2025; TTM through Dec 2025 was -$14.0 million, a 154.35% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 55144.44% from the prior year.
  • Other Non Operating Income slipped to -$10.0 million in Q4 2025 per PBH's latest filing, from -$501000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $51.6 million in Q1 2024 and bottomed at -$91.0 million in Q1 2021.
  • The 5-year median for Other Non Operating Income is -$2.4 million (2022), against an average of -$10.7 million.
  • Across the five-year window, Other Non Operating Income plunged 149620.0% in 2021 and soared 11337.25% in 2024, its largest moves.
  • Year by year, Other Non Operating Income stood at -$17.1 million in 2021, then soared by 93.28% to -$1.2 million in 2022, then jumped by 40.7% to -$682000.0 in 2023, then tumbled by 1631.38% to -$11.8 million in 2024, then climbed by 15.27% to -$10.0 million in 2025.
  • Per Business Quant, the three latest PBH Other Non Operating Income figures stand at -$10.0 million (Q4 2025), -$501000.0 (Q3 2025), and $224000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.01 Mn
Sep 30, 2025 -501,000.00
Jun 30, 2025 224,000.00
Mar 31, 2025 -3.71 Mn
Dec 31, 2024 -11.81 Mn
Sep 30, 2024 -395,000.00
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 51.58 Mn
Dec 31, 2023 -682,000.00
Sep 30, 2023 -17.84 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 451,000.00
Dec 31, 2022 -1.15 Mn
Sep 30, 2022 -812,000.00
Jun 30, 2022 790,000.00
Mar 31, 2022 -65.34 Mn
Dec 31, 2021 -17.10 Mn
Sep 30, 2021 -18.93 Mn
Jun 30, 2021 -14.97 Mn
Mar 31, 2021 -90.96 Mn